Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

1,061 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Severe Asthma Network Italy Definition of Clinical Remission in Severe Asthma: A Delphi Consensus.
Canonica GW, Blasi F, Carpagnano GE, Guida G, Heffler E, Paggiaro P, Allegrini C, Antonelli A, Aruanno A, Bacci E, Bagnasco D, Beghè B, Bonavia M, Bonini M, Brussino L, Caiaffa MF, Calabrese C, Camiciottoli G, Caminati M, Caruso C, Cavallini M, Chieco Bianchi F, Conte ME, Corsico AG, Cosmi L, Costantino M, Costanzo G, Crivellaro M, D'Alò S, D'Amato M, Detoraki A, Di Proietto MC, Facciolongo NC, Ferri S, Fierro V, Foschino MP, Latorre M, Lombardi C, Macchia L, Milanese M, Montagni M, Parazzini EM, Parente R, Passalacqua G, Patella V, Pelaia G, Pini L, Puggioni F, Ricciardi L, Ridolo E, Rolo J, Scichilone N, Scioscia G, Senna G, Solidoro P, Varricchi G, Vianello A, Yacoub MR, Yang B. Canonica GW, et al. J Allergy Clin Immunol Pract. 2023 Dec;11(12):3629-3637. doi: 10.1016/j.jaip.2023.07.041. Epub 2023 Aug 7. J Allergy Clin Immunol Pract. 2023. PMID: 37558162 Free article. Review.
Cetirizine reduces inflammatory cell recruitment and ICAM-1 (or CD54) expression on conjunctival epithelium in both early- and late-phase reactions after allergen-specific challenge.
Ciprandi G, Buscaglia S, Pesce G, Passalacqua G, Rihoux JP, Bagnasco M, Canonica GW. Ciprandi G, et al. Among authors: canonica gw. J Allergy Clin Immunol. 1995 Feb;95(2):612-21. doi: 10.1016/s0091-6749(95)70324-1. J Allergy Clin Immunol. 1995. PMID: 7531732 Clinical Trial.
Alternative routes for allergen-specific immunotherapy.
Passalacqua G, Canonica GW. Passalacqua G, et al. Among authors: canonica gw. J Investig Allergol Clin Immunol. 1996 Mar-Apr;6(2):81-7. J Investig Allergol Clin Immunol. 1996. PMID: 8727263 Review.
Topical azelastine reduces eosinophil activation and intercellular adhesion molecule-1 expression on nasal epithelial cells: an antiallergic activity.
Ciprandi G, Pronzato C, Passalacqua G, Ricca V, Grögen J, Mela GS, Varese P, Bertolini C, Bagnasco M, Canonica GW. Ciprandi G, et al. Among authors: canonica gw. J Allergy Clin Immunol. 1996 Dec;98(6 Pt 1):1088-96. doi: 10.1016/s0091-6749(96)80196-5. J Allergy Clin Immunol. 1996. PMID: 8977510 Clinical Trial.
Seasonal rhinitis and azelastine: long- or short-term treatment?
Ciprandi G, Ricca V, Passalacqua G, Truffelli T, Bertolini C, Fiorino N, Riccio AM, Bagnasco M, Canonica GW. Ciprandi G, et al. Among authors: canonica gw. J Allergy Clin Immunol. 1997 Mar;99(3):301-7. doi: 10.1016/s0091-6749(97)70046-0. J Allergy Clin Immunol. 1997. PMID: 9058684 Clinical Trial.
1,061 results